Results for 'nonviral'

Order:
  1.  21
    Latest Advances for the Sleeping Beauty Transposon System: 23 Years of Insomnia but Prettier than Ever.Maximilian Amberger & Zoltán Ivics - 2020 - Bioessays 42 (11):2000136.
    The Sleeping Beauty transposon system is a nonviral DNA transfer tool capable of efficiently mediating transposition‐based, stable integration of DNA sequences of choice into eukaryotic genomes. Continuous refinements of the system, including the emergence of hyperactive transposase mutants and novel approaches in vectorology, greatly improve upon transposition efficiency rivaling viral‐vector‐based methods for stable gene insertion. Current developments, such as reversible transgenesis and proof‐of‐concept RNA‐guided transposition, further expand on possible applications in the future. In addition, innate advantages such as lack (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  2.  41
    Gene therapy for neurodegenerative disorders and malignant brain tumors.Lan Chiang, Eric P. Flores, Dennis Y. Wen, Walter A. Hall & Walter C. Low - 1995 - Behavioral and Brain Sciences 18 (1):52-53.
    Gene therapy approaches have great promise in the treatment of neurodegenerative disorders and malignant brain tumors. Neuwelt et al. review available viral-mediated gene therapy methods and their blood-brain-barrier (BBB) disruption delivery technique, briefly mentioning nonviral mediated gene therapy methods. This commentary discussed the BBB disruption delivery technique, viral and nonviral mediated gene therapy approaches to Parkinson's disease, and the potential use of antisense oligo to suppress malignant brain tumors.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  3.  22
    The limitations of central nervous systemdirected gene transfer.Beverly L. Davidson - 1995 - Behavioral and Brain Sciences 18 (1):54-55.
    Complementation and correction of a genetic defect with CNS manifestations lags behind gene therapy for inherited disorders affecting other organ systems because of shortcomings in delivery vehicles and access to the CNS. The effects of improvements in viral and nonviral vectors, coupled with the development of delivery strategies designed to transfer genetic material thoughout the CNS are being investigated by a number of laboratories in efforts to overcome these problems.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark